Skip to main content
. 2021 Sep 24;70(12):2879–2891. doi: 10.2337/db21-0259

Figure 3.

Figure 3

Blood CD8+ T cells recognize either R- or X-GRP78 peptide versions in adolescents with type 1 diabetes. A: Frequencies of MMr+CD8+ cells reactive exclusively to the GRP78-R (blue symbols) or GRP78-X (red symbols) peptides, or to both (green symbols), in HLA-A2+ adolescents with type 1 diabetes (T1D) (n = 8). PPI6–14 and Flu MP58–66 peptides were included as controls. At least 0.39 × 106 CD8+ T cells were counted for each donor (median 1.1 × 106 [range 0.39–2.4 × 106]). B: Percentage of antigen-experienced cells out of total MMr+ cells for the GRP78 peptides depicted in A. Data points with <5 MMr+ cells were excluded (median 15 MMr+ cells [range 5–115] for GRP78 peptides). Bars show median values. NA, not available (i.e., <5 MMr+ cells counted). *P < 0.05, **P < 0.01, ***P < 0.001 by Mann-Whitney U test.